Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

SmithKline Beecham describes 5-HT1D antagonists

June 14, 1996

Compounds with melatonin receptor affinity from Takeda

June 14, 1996

5-HT2B/2C antagonists reported by SmithKline Beecham

June 14, 1996

Further ADIR research on melatonergic compounds

June 14, 1996

Zeneca reveals prostaglandin antagonists

June 14, 1996

ADIR claims tachykinin antagonists

June 14, 1996

Dopamine D4 receptor ligands discovered by Pfizer

June 7, 1996

Clinical trials anticipated for CoCensys' and Ciba-Geigy's codeveloped EAA antagonist

June 7, 1996

Ciba-Geigy discloses glycine-site NMDA antagonists

June 7, 1996

BASF reports glutamate receptor antagonists

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...